About
Pathos AI is an artificial intelligence-driven biotechnology company specializing in oncology drug development. Leveraging large multimodal datasets and proprietary machine learning models, Pathos AI aims to identify promising drug targets and optimize clinical trial design to improve outcomes for cancer patients. The company integrates genomic, transcriptomic, and real-world clinical information to predict drug efficacy and accelerate the progression of novel therapies.
With leadership experienced in both AI and precision medicine, Pathos AI is positioned at the forefront of computational approaches for transformative cancer treatments.
